+194.3%
NVDL vs EMR
+90.8%
+103.5%
-67.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.0% | +1.8% | -7.8% | -8.2% |
| 7D | -25.3% | -2.7% | -22.6% | -22.8% |
| 30D | -53.6% | +1.3% | -54.9% | -54.1% |
| 3M | -56.4% | +3.0% | -59.4% | -57.8% |
| 6M | -60.0% | +23.4% | -83.4% | -69.1% |
| YTD | -48.1% | +23.9% | -71.9% | -62.7% |
| 1Y | -46.4% | +29.7% | -76.1% | -64.3% |
| All | +194.3% | +90.8% | +103.5% | +41.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling